Systems and methods for targeted imaging and ablation of cardiac cells
US-2015328315-A1 · Nov 19, 2015 · US
US10493039B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10493039-B2 |
| Application number | US-201615757092-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 16, 2016 |
| Priority date | Sep 3, 2015 |
| Publication date | Dec 3, 2019 |
| Grant date | Dec 3, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A nanocapsule includes a liquid hydrophobic care including an essential oil, and a shell encapsulating the core. The shell includes a copolymer having repeating units of Formula (I) and (II) wherein X, L 1 , R 1 , R 2 , y, and p are as described herein. A dispersion is also disclosed, wherein the dispersion includes a plurality of nanocapsules. The nanocapsules described herein are particularly useful for the treatment of bacterial biofilms.
Opening claim text (preview).
The invention claimed is: 1. A nanocapsule comprising, a liquid hydrophobic core comprising an essential oil; and a shell encapsulating the core, the shell comprising a copolymer comprising repeating units of Formula (I) and (II) wherein X is independently at each occurrence —O—, —S—, —CH 2 —, —(CR 4 R 5 )—, or wherein R 4 and R 5 are independently at each occurrence a C 1-6 alkyl group and R 6 and R 7 are independently at each occurrence hydrogen or a C 1-6 alkyl group; L 1 is independently at each occurrence a divalent group that is (—CH 2 —) z , wherein z is an integer from 1 to 10, a divalent a C 1-20 alkylene oxide group, or a divalent poly(C 1-6 alkylene oxide) group; R 1 is independently at each occurrence hydrogen, a C 1-12 alkylene group, or a —C(═O)—O—(C 1-6 alkyl) group; y is 2 or 3; p is 0 or 1; and R 2 is independently at each occurrence a C 1-12 alkylene group, a C 6-20 arylene group, a C 1-20 alkylene oxide group, a poly(C 1-6 alkylene oxide) group, or a zwitterionic group. 2. The nanocapsule of claim 1 , wherein the copolymer further comprises repeating units of Formula (III) wherein X is independently at each occurrence —O—, —S—, —CH 2 —, —(CR 4 R 5 )—, or wherein R 4 and R 5 are independently at each occurrence a C 1-6 alkyl group and R 6 and R 7 are independently at each occurrence hydrogen or a C 1-6 alkyl group; L 2 is independently at each occurrence a divalent group that is (—CH 2 —) z , wherein z is an integer from 1 to 10, a divalent a C 1-20 alkylene oxide group, or a divalent poly(C 1-6 alkylene oxide) group; R 3 is independently at each occurrence hydrogen, a C 1-12 alkylene group, or a —C(═O)—O—(C 1-6 alkyl) group; a is 2 or 3; and b is 0 or 1. 3. The nanocapsule of claim 1 , wherein the copolymer further comprises repeating units of Formula (IV). 4. The nanocapsule of claim 1 , wherein the copolymer further comprises repeating units of Formula (V) wherein X is independently at each occurrence —O—, —S—, —CH 2 —, —(CR 4 R 5 )—, or wherein R 4 and R 5 are independently at each occurrence a C 1-6 alkyl group and R 6 and R 7 are independently at each occurrence hydrogen or a C 1-6 alkyl group; R 2 is independently at each occurrence a C 1-12 alkylene group, a C 6-20 arylene group, a C 1-20 alkylene oxide group, a poly(C 1-6 alkylene oxide) group, or a zwitterionic group; and L 3 is a divalent group that is (—CH 2 —) z , wherein z is an integer from 1 to 10. 5. The nanocapsule of claim 1 , wherein the core further comprises a hydrophobic anhydride-containing polymer in an amount of 0.01 to 15 weight percent, based on the weight of the core, wherein the hydrophobic anhydride-containing polymer comprising repeating units of Formula (VI) wherein R 8 is independently at each occurrence a hydrogen, a C 1-20 alkyl group or a C 6-20 aryl group. 6. The nanocapsule of claim 5 , wherein at least a portion of the shell is crosslinked with the anhydride-containing polymer. 7. The nanocapsule of claim 1 , wherein the essential oil is selected from the group consisting of peppermint oil, oregano oil, thymol, menthol, methyl salicylate, eucalyptol, carvacrol, camphor, anethole, carvone, eugenol, isoeugenol, limonene, osimen, n-decyl alcohol, citronel, a-salpineol, methyl acetate, citronellyl acetate, methyl eugenol, cineol, linalool, ethyl linalaol, safrola vanillin, spearmint oil, lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil, pimento oil, laurel oil, cedar leaf oil, clove oil, cilantro oil, coriander oil, or a combination thereof. 8. The nanocapsule of claim 2 , wherein the copolymer comprises 5 to 50 mole percent repeating units of Formula (I); 10 to 50 mole percent repeating units of Formula (II); and 25 to 45 mole percent repeating units of Formula (III); wherein mole percent of each component is based on the total moles of the copolymer. 9. The nanocapsule of claim 1 , wherein X is —O—; L 1 is propylene; R 1 is hydrogen; y is 3; p is 1; and R 2 is a C 1-20 alkylene oxide group. 10. The nanocapsule of claim 1 , wherein R 2 is a group having the structure wherein n is 1, 2, 3, or 4; and R 10 is hydrogen, methyl, or a C 1-6 alkylamino group. 11. The nanocapsule of claim 2 , wherein R 3 is hydrogen; L 2 is propylene; a is 3; and b is 1. 12. The nanocapsule of claim 1 , wherein the copolymer has a number average molecular weight of 3,000 to 100,000 Daltons. 13. The nanocapsule of claim 1 , comprising 90 to 99.9 weight percent of the core; and 0.1 to 10 weight percent of the shell; wherein weight percent is based on the total weight of the nanocapsule. 14. The nanocapsule of claim 1 , wherein the nanocapsule comprises 1 to 10 weight percent, based on the weight of the nanocapsule, of the core comprising carvacrol oil; and 90 to 99 weight percent, based on the weight of the nanocapsule, of the shell comprising the copolymer, wherein each occurrence of X is —O—; each occurrence of L 1 is propylene; each occurrence of R 1 is hydrogen; each occurrence of y is 3; each occurrence of p is 1; each occurrence of R 2 is a group having the structure wherein n is 4; and the nanocapsule has a diameter of 1 to 100 nanometers. 15. The nanocapsule of claim 2 , wherein the nanocapsule comprises 1 to 10 weight percent, based on the weight of the nanocapsule, of the core comprising 85 to 99.99 weight percent, based on the weight of the core, of carvacrol oil; and 0.01 to 15 weight percent, based on the weight of the core, of the hydrophobic anhydride containing polymer comprising repeating units of Formula (VI) wherein m is an integer from 1 to 16; and 90 to 99 weight percent, based on the weight of the nanocapsule, of the shell comprising the copolymer, wherein each occurrence of X is —O—; each occurrence of L 1 and L 2 are propylene; each occurrence of R 1 is hydrogen; each occurrence of y is 3; each occurrence of p is 1; each occurrence of R 2 is a group having the structure wherein n is 4; each occurrence of R 3 is hydrogen; each occurrence of
Ring opening metathesis polymerisation [ROMP] · CPC title
having no condensed rings · CPC title
obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates · CPC title
of carbocyclic compounds containing one or more carbon-to-carbon double bonds in the ring · CPC title
Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.